Xovoltib 40mg (Afatinib Dimaleate Tablet) 40mg

Xovoltib 40mg (Afatinib Dimaleate) tablets are prescribed for targeted therapy in certain cancer types. This oral medication supports treatment plans for specific conditions. Suitable for adults under medical supervision. Always follow healthcare provider instructions when using Xovoltib 40mg.

Strength

40mg

Pack Size

28s

Storage

Ambient

Manufacturer / TM Owner

Boehringer Ingelheim Pharma GmbH

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Xovoltib 40mg is used in targeted cancer therapy to inhibit abnormal protein activity. It is prescribed for patients with specific tumor types as part of a broader treatment strategy. The 40mg strength supports consistent dosing in adult regimens. Always consult a healthcare professional for suitability.

Side Effects

Xovoltib 40mg works by targeting cancer cells to slow their growth. Patients may experience effects related to its mechanism of action during treatment. Common effects vary by individual and treatment phase.

Precautions & Warnings

Store Xovoltib 40mg at room temperature away from moisture and heat. Keep out of reach of children and pets. Handle with care and follow disposal guidelines for unused medication. Report any unusual reactions to your healthcare provider promptly.

Avoid Interactions

Xovoltib 40mg may interact with other medications, including certain supplements and herbal products. Avoid grapefruit products unless approved by a doctor. Discuss all current medications with your healthcare provider before starting treatment.

References

Frequently Asked Questions

Xovoltib 40mg is used in targeted cancer therapy for specific tumor types as prescribed by a healthcare provider.

Store Xovoltib 40mg at room temperature, away from moisture and direct heat, in its original packaging.

Consult your healthcare provider before combining Xovoltib 40mg with other drugs, supplements, or herbal products.

Xovoltib 40mg is prescribed for specific cancer types; suitability depends on individual medical conditions and treatment plans.

If a dose is missed, follow your healthcare provider’s guidance; do not take a double dose without consulting them.

Published by GNH India Pharmaceuticals Limited

Last updated: 17 Jun 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.